73,99 €
Updated with new chapters and topics, this book provides a comprehensive description of all essential topics in contemporary pharmacokinetics and pharmacodynamics. It also features interactive computer simulations for students to experiment and observe PK/PD models in action.
• Presents the essentials of pharmacokinetics and pharmacodynamics in a clear and progressive manner
• Helps students better appreciate important concepts and gain a greater understanding of the mechanism of action of drugs by reinforcing practical applications in both the book and the computer modules
• Features interactive computer simulations, available online through a companion website at: https://web.uri.edu/pharmacy/research/rosenbaum/sims/
• Adds new chapters on physiologically based pharmacokinetic models, predicting drug-drug interactions, and pharmacogenetics while also strengthening original chapters to better prepare students for more advanced applications
• Reviews of the 1st edition: “This is an ideal textbook for those starting out … and also for use as a reference book …." (International Society for the Study of Xenobiotics) and “I could recommend Rosenbaum’s book for pharmacology students because it is written from a perspective of drug action . . . Overall, this is a well-written introduction to PK/PD …. “ (British Toxicology Society Newsletter)
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 1080
Veröffentlichungsjahr: 2016
Second Edition
Edited by
SARA E. ROSENBAUM
Copyright © 2017 by John Wiley & Sons, Inc. All rights reserved.
Published by John Wiley & Sons, Inc., Hoboken, New Jersey. Published simultaneously in Canada.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permission.
Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www.wiley.com.
Library of Congress Cataloging-in-Publication Data:
Names: Rosenbaum, Sara (Sara E.), author, editor. Title: Basic pharmacokinetics and pharmacodynamics : an integrated textbook and computer simulations / edited by Sara E. Rosenbaum. Description: Second edition. | Hoboken, New Jersey : John Wiley & Sons, Inc., [2017] | Includes bibliographical references and index. Identifiers: LCCN 2016031846 (print) | LCCN 2016034126 (ebook) | ISBN 9781119143154 (pbk.) | ISBN 9781119143161 (pdf) | ISBN 9781119143185 (epub) Subjects: | MESH: Pharmacokinetics | Pharmacological Phenomena | Computer Simulation Classification: LCC RM301.5 (print) | LCC RM301.5 (ebook) | NLM QV 38 | DDC 615/.7–dc23 LC record available at https://lccn.loc.gov/2016031846
To Steve, Molly and Lucy
Preface
Contributors
Chapter 1 Introduction to Pharmacokinetics and Pharmacodynamics
1.1 Introduction: Drugs and Doses
1.2 Introduction to Pharmacodynamics
1.3 Introduction to Pharmacokinetics
1.4 Dose–Response Relationships
1.5 Therapeutic Range
1.6 Summary
Reference
Chapter 2 Passage of Drugs Through Membranes
2.1 Introduction
2.2 Structure and Properties of Membranes
2.3 Passive Diffusion
2.4 Carrier-Mediated Processes: Transport Proteins
References
Chapter 3 Drug Administration and Drug Absorption
3.1 Introduction: Local and Systemic Drug Administration
3.2 Routes of Drug Administration
3.3 Overview of Oral Absorption
3.4 Extent of Drug Absorption
3.5 Determinants of the Fraction of the Dose Absorbed (
F
)
3.6 Factors Controlling the Rate of Drug Absorption
3.7 Biopharmaceutics Classification System
3.8 Food Effects
Problems
References
Chapter 4 Drug Distribution
4.1 Introduction
4.2 Extent of Drug Distribution
4.3 Rate of Drug Distribution
4.4 Distribution of Drugs to the Central Nervous System
Problems
Note
References
Chapter 5 Drug Elimination and Clearance
5.1 Introduction
5.2 Clearance
5.3 Renal Clearance
5.4 Hepatic Elimination and Clearance
Problems
References
Chapter 6 Compartmental Models in Pharmacokinetics
6.1 Introduction
6.2 Expressions for Component Parts of the Dose–Plasma Concentration Relationship
6.3 Putting Everything Together: Compartments and Models
6.4 Examples of Complete Compartment Models
6.5 Use of Compartmental Models to Study Metabolite Pharmacokinetics
6.6 Selecting and Applying Models
Problems
Suggested Readings
Chapter 7 Pharmacokinetics of an Intravenous Bolus Injection in a One-Compartment Model
7.1 Introduction
7.2 One-Compartment Model
7.3 Pharmacokinetic Equations
7.4 Simulation Exercise
7.5 Application of the Model
7.6 Determination of Pharmacokinetic Parameters Experimentally
7.7 Pharmacokinetic Analysis in Clinical Practice
Problems
Suggested Reading
Chapter 8 Pharmacokinetics of an Intravenous Bolus Injection In A Two-Compartment Model
8.1 Introduction
8.2 Tissue and Compartmental Distribution of a Drug
8.3 Basic Equation
8.4 Relationship Between Macro and Micro Rate Constants
8.5 Primary Pharmacokinetic Parameters
8.6 Simulation Exercise
8.7 Determination of the Pharmacokinetic Parameters of the Two-Compartment Model
8.8 Clinical Application of the Two-Compartment Model
Problems
Suggested Readings
Chapter 9 Pharmacokinetics of Extravascular Drug Administration
9.1 Introduction
9.2 First-Order Absorption in a One-Compartment Model
9.3 Modified Release and Gastric Retention Formulations
9.4 Bioavailability
9.5
IN VITRO-IN VIVO
Correlation
9.6 Simulation Exercise
Problems
References
Chapter 10 Introduction to Noncompartmental Analysis
10.1 Introduction
10.2 Mean Residence Time
10.3 Determination of Other Important Pharmacokinetic Parameters
10.4 Different Routes of Administration
10.5 Application of Noncompartmental Analysis to Clinical Studies
Problems
Chapter 11 Pharmacokinetics of Intravenous Infusion in a One-Compartment Model
11.1 Introduction
11.2 Model and Equations
11.3 Steady-State Plasma Concentration
11.4 Loading Dose
11.5 Termination of Infusion
11.6 Individualization of Dosing Regimens
Problems
Chapter 12 Multiple Intravenous Bolus Injections in the One-Compartment Model
12.1 Introduction
12.2 Terms and Symbols Used in Multiple-Dosing Equations
12.3 Monoexponential Decay During a Dosing Interval
12.4 Basic Pharmacokinetic Equations for Multiple Doses
12.5 Steady State
12.6 Basic Formula Revisited
12.7 Pharmacokinetic-Guided Dosing Regimen Design
12.8 Simulation Exercise
Problems
Reference
Chapter 13 Multiple Intermittent Infusions
13.1 Introduction
13.2 Steady-State Equations for Multiple Intermittent Infusions
13.3 Monoexponential Decay During a Dosing Interval: Determination of Peaks, Troughs, and Elimination Half-Life
13.4 Determination of the Volume of Distribution
13.5 Individualization of Dosing Regimens
13.6 Simulation
Problems
Chapter 14 Multiple Oral Doses
14.1 Introduction
14.2 Steady-State Equations
14.3 Equations Used Clinically to Individualize Oral Doses
14.4 Simulation Exercise
References
Chapter 15 Nonlinear Pharmacokinetics
15.1 Linear Pharmacokinetics
15.2 Nonlinear Processes in Absorption, Distribution, Metabolism, and Elimination
15.3 Pharmacokinetics of Capacity-Limited Metabolism
15.4 Phenytoin
Problems
References
Chapter 16 Introduction to Pharmacogenetics
16.1 Introduction
16.2 Genetics Primer
16.3 Pharmacogenetics
16.4 Genetics and Pharmacodynamics
16.5 Summary
Reference
Suggested Readings
Chapter 17 Models Used to Predict Drug–Drug Interactions for Orally Administered Drugs
17.1 Introduction
17.2 Mathematical Models for Inhibitors and Inducers of Drug Metabolism Based on
IN VITRO
Data
17.3 Surrogate
IN VIVO
Values for the Unbound Concentration of the Perpetrator at the site of action
17.4 Models Used to Predict DDIs
IN VIVO
17.5 Predictive Models for Transporter-Based DDIs
17.6 Application of Physiologically Based Pharmacokinetic Models to DDI Prediction: The Dynamic Approach
17.7 Conclusion
Problems
References
Chapter 18 Introduction to Physiologically Based Pharmacokinetic Modeling
18.1 Introduction
18.2 Components of PBPK Models
18.3 Equations for PBPK Models
18.4 Building a PBPK Model
18.5 Simulations
18.6 Estimation of Human Drug-Specific Parameters
18.7 More Detailed PBPK Models
18.8 Application of PBPK Models
References
Chapter 19 Introduction to Pharmacodynamic Models and Integrated Pharmacokinetic–Pharmacodynamic Models
19.1 Introduction
19.2 Classic Pharmacodynamic Models Based on Receptor Theory
19.3 Direct Effect Pharmacodynamic Models
19.4 Integrated PK–PD Models: Intravenous Bolus Injection in the One-Compartment Mode and the Sigmoidal
E
max
Model
19.5 Pharmacodynamic Drug–Drug Interactions
Problems
References
Chapter 20 Semimechanistic Pharmacokinetic–Pharmacodynamic Models
20.1 Introduction
20.2 Hysteresis and the Effect Compartment
20.3 Physiological Turnover Models and Their Characteristics
20.4 Indirect Effect Models
20.5 Other Indirect Effect Models
20.6 Models of Tolerance
20.7 Irreversible Drug Effects
20.8 Disease Progression Models
Problems
References
Appendix A Review of Exponents and Logarithms
A.1 Exponents
A.2 Logarithms: Log and Ln
A.3 Performing Calculations in the Logarithmic Domain
A.4 Calculations Using Exponential Expressions and Logarithms
A.5 Decay Function:
e
−
kt
A.6 Growth Function: 1 −
e
−
kt
A.7 Decay Function in Pharmacokinetics
Problems
Appendix B Rates of Processes
B.1 Introduction
B.2 Order of a Rate Process
B.3 Zero-Order Processes
B.4 First-Order Processes
B.5 Comparison of Zero- and First-Order Processes
B.6 Detailed Example of First-Order Decay in Pharmacokinetics
B.7 Examples of the Application of First-Order Kinetics to Pharmacokinetics
Appendix C Creation of Excel Worksheets for Pharmacokinetic Analysis
C.1 Measurement of AUC and Clearance
C.2 Analysis of Data from an Intravenous Bolus Injection in a One-Compartment Model
C.3 Analysis of Data from an Intravenous Bolus Injection in a Two-Compartment Model
C.4 Analysis of Oral Data in a One-Compartment Model
C.5 Noncompartmental Analysis of Oral Data
Appendix D Derivation of Equations for Multiple Intravenous Bolus Injections
D.1 Assumptions
D.2 Basic Equation for Plasma Concentration After Multiple Intravenous Bolus Injections
D.3 Steady-State Equations
Appendix E Enzyme Kinetics: Michaelis–Menten Equation and Models for Inhibitors and Inducers of Drug Metabolism
E.1 Kinetics of Drug Metabolism: The Michaelis–Menten Model
E.2 Effect of Perpetrators of DDI on Enzyme Kinetics and Intrinsic Clearance
References
Appendix F Summary of the Properties of the Fictitious Drugs used in the Text
Appendix G Computer Simulation Models
Glossary of Terms
Index
EULA
Chapter 1
Table 1.1
Table 1.2
Table 1.3
Chapter 2
Table 2.1
Table 2.2
Table 2.3
Table 2.4
Chapter 3
Table 3.1
Table 3.2
Table 3.3
Table 3.4
Table 3.5
Table 3.6
Table P3.7
Chapter 4
Table 4.1
Table 4.2
Table 4.3
Table 4.4
Table 4.5
Table 4.6
Table 4.7
Table P4.7
Chapter 5
Table 5.1
Table 5.2
Table 5.3
Table E5.3A
Table E5.3B
Table 5.4
Table 5.5
Table 5.6
Table 5.7
Table 5.8
Table 5.9
Table P5.11
Table P5.12
Table P5.13
Chapter 7
Table 7.1
Table 7.2
Table SE7.4
Table E7.5
Table E7.6
Table P7.8
Chapter 8
Table 8.1
Table E8.1
Table P8.4
Table P8.5
Table P8.7
Table E9.1A
Chapter 9
Table E9.1B
Table 9.1
Table P9.1
Table P9.2
Chapter 10
Table E10.1
Table E10.2A
Table E10.2B
Table E10.3A
Table E10.3B
Table P10.1
Table P10.2
Table P10.3
Chapter 11
Table SE11.1
Table 11.1
Table SE11.2
Table P11.5
Chapter 12
Table 12.1
Table 12.2
Table SE12.1
Table SE12.2
Table SE12.3
Chapter 13
Table E13.3
Table P13.4
Chapter 15
Table 15.1
Table 15.2
Chapter 16
Table 16.1
Table 16.2
Chapter 17
Table 17.1
Table 17.2
Table 17.3
Table 17.4
Chapter 18
Table 18.1
Table 18.2
Table 18.3
Chapter 20
Table 20.1
Table 20.2
Table 20.3
Table P20.1A
Table P20.1B
Table P20.2A
Table P20.2B
Table P20.3
Table P20.5
Table P20.6
Table P20.7
Appendix A
Table A.1
Table A.2
Appendix B
Table B.1
Table B.2
Appendix C
Table C.1
Table C.2
Table C.3
Table C.4
Appendix D
Table D.1
Appendix F
Table F.1
